Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Torrent Pharmaceuticals Ltd ( (IN:TORNTPHARM) ) has provided an update.
Torrent Pharmaceuticals has notified stock exchanges that it has published newspaper advertisements in the Indian Express and Sandesh detailing a National Company Law Tribunal convened meeting of its equity shareholders. The meeting, ordered by the NCLT on March 23, 2026, is scheduled for April 28, 2026, and will be conducted via video conferencing and other audio-visual means, underscoring formal compliance with listing regulations and signaling an upcoming shareholder decision on a matter significant enough to require tribunal oversight.
The company has submitted these publication copies under Regulation 30 of SEBI’s Listing Obligations and Disclosure Requirements, reinforcing transparency with investors and regulators. By formally documenting the tribunal-directed shareholders’ meeting and its virtual format, Torrent Pharma highlights its adherence to corporate governance norms and ensures that stakeholders are adequately informed about key corporate proceedings.
More about Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd. is an Indian pharmaceutical company engaged in the manufacture and marketing of generic and branded formulations. It focuses on prescription medicines across therapeutic areas for domestic and international markets, and its equity shares are listed on both BSE and the National Stock Exchange of India.
Average Trading Volume: 9,336
Technical Sentiment Signal: Buy
Current Market Cap: 1443.9B INR
See more data about TORNTPHARM stock on TipRanks’ Stock Analysis page.

